JP2010516817A5 - - Google Patents

Download PDF

Info

Publication number
JP2010516817A5
JP2010516817A5 JP2009548391A JP2009548391A JP2010516817A5 JP 2010516817 A5 JP2010516817 A5 JP 2010516817A5 JP 2009548391 A JP2009548391 A JP 2009548391A JP 2009548391 A JP2009548391 A JP 2009548391A JP 2010516817 A5 JP2010516817 A5 JP 2010516817A5
Authority
JP
Japan
Prior art keywords
compound
pharmaceutically acceptable
acceptable salt
formula
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009548391A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010516817A (ja
JP5566692B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/052318 external-priority patent/WO2008094912A2/en
Publication of JP2010516817A publication Critical patent/JP2010516817A/ja
Publication of JP2010516817A5 publication Critical patent/JP2010516817A5/ja
Application granted granted Critical
Publication of JP5566692B2 publication Critical patent/JP5566692B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009548391A 2007-01-31 2008-01-29 治療薬としての置換ガンマラクタム類 Expired - Fee Related JP5566692B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88741507P 2007-01-31 2007-01-31
US60/887,415 2007-01-31
PCT/US2008/052318 WO2008094912A2 (en) 2007-01-31 2008-01-29 Substituted gamma lactams as therapeutic agents

Publications (3)

Publication Number Publication Date
JP2010516817A JP2010516817A (ja) 2010-05-20
JP2010516817A5 true JP2010516817A5 (enExample) 2011-03-10
JP5566692B2 JP5566692B2 (ja) 2014-08-06

Family

ID=39639429

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009548391A Expired - Fee Related JP5566692B2 (ja) 2007-01-31 2008-01-29 治療薬としての置換ガンマラクタム類

Country Status (11)

Country Link
US (1) US7960381B2 (enExample)
EP (1) EP2121672B1 (enExample)
JP (1) JP5566692B2 (enExample)
KR (1) KR101561706B1 (enExample)
CN (1) CN101595106B (enExample)
AU (1) AU2008210559B2 (enExample)
BR (1) BRPI0808377B8 (enExample)
CA (1) CA2676291C (enExample)
MX (1) MX2009008039A (enExample)
NZ (1) NZ578698A (enExample)
WO (1) WO2008094912A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8377984B2 (en) * 2008-01-29 2013-02-19 Allergan, Inc. Substituted gamma lactams as therapeutic agents
CN102076681A (zh) * 2008-04-24 2011-05-25 阿勒根公司 作为治疗剂的取代γ-内酰胺
US7713968B2 (en) 2008-04-24 2010-05-11 Allergan, Inc. Substituted arylcyclopentenes as therapeutic agents
EP2291367A1 (en) * 2008-04-24 2011-03-09 Allergan, Inc. Substituted gamma lactams as therapeutic agents
RU2010149494A (ru) * 2008-05-09 2012-06-20 Аллерган, Инк. (Us) Терапевтические замещенные тиазолидиноны, оксазолидиноны и родственные соединения
US8124648B2 (en) * 2008-05-20 2012-02-28 Allergan, Inc. Therapeutic lactams

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040015364A (ko) * 2001-07-16 2004-02-18 에프. 호프만-라 로슈 아게 Ep4 수용체 작용물질로서의 프로스타글란딘 유사체
CN1617868A (zh) * 2001-11-05 2005-05-18 阿勒根公司 作为EP2-受体激动剂的ω-环烷基17-杂芳基前列腺素E2 类似物
NZ535024A (en) * 2002-03-05 2006-10-27 Ono Pharmaceutical Co 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient
US6573294B1 (en) * 2002-05-14 2003-06-03 Allergan, Inc. 8-azaprostaglandin analogs as agents for lowering intraocular pressure
EP1556347A4 (en) * 2002-06-10 2006-08-09 Applied Research Systems GAMMA LACTAME AS PROSTAGLAND INAGONISTS AND THEIR USE
US7091231B2 (en) * 2004-12-10 2006-08-15 Allergan, Inc. 12-Aryl prostaglandin analogs
BRPI0609021A2 (pt) * 2005-03-10 2010-01-12 Allergan Inc gama lactamas substituìdas, composição e uso das mesmas
EP1996546B1 (en) * 2006-03-20 2014-11-26 Allergan, Inc. Substituted gamma lactams as prostaglandin ep2 agonists

Similar Documents

Publication Publication Date Title
WO2006098918B1 (en) Substituted gamma lactams as therapeutic agents
JP2010516817A5 (enExample)
JP2010524932A5 (enExample)
EP1857457A3 (en) Benzimidazole derivative and its use as AII receptor antagonist
JP2005112864A5 (enExample)
JP2010077141A5 (enExample)
JP2007533740A5 (enExample)
JP2011509309A5 (enExample)
JP2011504903A5 (enExample)
JP2013542247A5 (enExample)
JP2011516511A5 (enExample)
JP2007517846A5 (enExample)
JP2005539088A5 (enExample)
JP2014521744A5 (enExample)
WO2012018534A3 (en) Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases
JP2009543795A5 (enExample)
JP2011512412A5 (enExample)
JP2013500342A5 (enExample)
JP2017511368A5 (enExample)
JP2014505723A5 (enExample)
JP2011509302A5 (enExample)
JP2004502732A5 (enExample)
JP2008517020A5 (enExample)
JP2010506919A5 (enExample)
JP2009543792A5 (enExample)